An observational study in Acute Myocardial Infarction, sponsored by Xiamen Cardiovascular Hospital, Xiamen University. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-26.
Sponsored by Xiamen Cardiovascular Hospital, Xiamen University · Observational
To determine the incidence and factors associated with heart rupture (HR) in acute myocardial infarction patients.
We compared characteristics and angiographic patterns of heart rupture and without heart rupture patients enrolled in the trial.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's planned enrollment of 35,621 is above the median of 500 across 983 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Xiamen Cardiovascular Hospital, Xiamen University is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population of acute myocardial infarction (STEMI or NSTEMI) patients.
Exclusion Criteria:
Include free wall ventricular rupture and ventricular septal rupture
Diagnostic Test: Heart rupture
Mechanical complications were not included in patients with AMI
Free wall rupture and Ventricular septal rupture
Heart rupture
Includee free wall ventricular rupture and ventricular septal rupture
Time frame: Mortality 30 days
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Xiamen Cardiovascular Hospital, Xiamen University